In clinical and prognostic studies, the expression of Oct4 and Nanog have been shown to be significantly correlated with a higher incidence of OSCC and lymph node metastasis [43,45]. Here, POU5F1 is linked to metastatic malignant neoplasm in the lymph nodes.